Asthma Drugs

Asthma Drugs Market to Reach US$ 37.3 Billion, Globally, by 2030

Share This Article

The asthma drugs market is expected to exhibit a CAGR of 5.2% from 2021 to 2030 and is projected to reach US$ 37.3 Billion by 2030, according to a 2021 study by Precedence Research, the Canada based market insight company.

The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global asthma drugs market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global asthma drugs market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the asthma drugs industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1225

Growth Factors:

Increasing prevalence of asthma across the globe is major factor driving growth of the global asthma drugs market. Asthma is deliberated as the common chronic diseases. Increasing need for better and improved health is creating huge demand for the asthma medications which will in turn fuel growth of the global market in the near future. As per the data published by Pharmaceutical Services Negotiating Committee (PSNC), in 2016, more than 5.5 million people in the UK received asthma treatment out of which 4.3 million were adults and 1.1 million asthma patients were children.

In order to cater the growing demand for asthma drugs, key market players are repeatedly launching advanced and innovative products at minimum costs which is will support and boost growth of the asthma industry in the next 10 years. For instance, in year 2019, AstraZeneca company’s asthma drug Fasenra has been approved by the Food and Drug Administration which is a pre filled and auto injector. Additionally, in the same year GlaxoSmithKline plc.’s Nucala has been approved by the Food and Drug Administration in order to treat severe eosinophilic asthma for the children in the six to eleven year of age group. This is the only biologic approved for the younger age group. Additionally, rising R&D activities, technological advancements, government support for creating health awareness are among major factors that will augment target industry growth during the forecast time-frame.

Report Coverage:

Report Highlights Details
Market Size USD 37.3 Billion by 2030
Growth Rate CAGR of 5.2% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Medication, Mode of Administration, Source, Organization Type, Application
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned GlaxoSmithKline, Pfizer, Vectura Group, Boehringer Ingelheim, Roche, Novartis, Merck, AstraZeneca, Teva Pharmaceutical

Report Highlights:

  • Among the asthma drugs medications type segment long-term control medications segment is dominated the overall market. The growth is attributed to growing need for the long-term control medications in order to treat chronic diseases that are considered as asthma. Further the quick relief medications segment is projected register significant share in the global industry owing its increased consumer base across the globe.
  • Novartis accounted for a significant share of the global asthma drugs market.
  • Tablets and capsules segment is expected to hold the prime revenue share by mode of administration.
  • Long-term control medications segment is expected to hold the prime revenue share by medication type.

Regional Analysis:
The research report deals with the industry prospects of asthma drugs products around regions including Europe, North America, Latin America, Asia-Pacific, and Middle East and Africa. North America will dominate the global industry due to huge investments in healthcare sector and growing research and development activities in the countries is predictable create tremendous demand for the asthma drugs, in the countries of the North America. Presence of leading players in the region along with strategies that are implemented by the major players in the countries of North America is expected to witness substantial growth in the target industry in the near future.

Asia Pacific is likely to list the noteworthy CAGR, on account of increased initiatives by the government in order to creates awareness regarding health in emerging economies. Also, most of the key players operating in the industry are investing heavily in order to get the competitive edge in the asthma drugs market in Asia Pacific. Addition to this growth of the European countries is attributed to the growing focus on research and development activities and increasing old age population in the France, Russia, and U.K. of the region. Latin America asthma drugs market is expected to grow at moderate CAGR in the near future. Also, Middle East and Africa region is expected to create lucrative growth opportunities in the target industry.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global asthma drugs market are as follows:

  • GlaxoSmithKline
  • Pfizer
  • Vectura Group
  • Boehringer Ingelheim
  • Roche
  • Novartis
  • Merck
  • AstraZeneca
  • Teva Pharmaceutical

Market Segmentation

By Medication

  • Quick Relief Medications
  • Long-term Control Medications
  • Others

By Mode of Administration

  • Tablets and Capsules
  • Liquids
  • Inhalers
  • Injections
  • Sprays and Powders

By Source

  • Environmental
  • Generic

By Organization Type

  • Public
  • Private

By Application

  • Pediatric
  • Adults
  • Adolescent

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global asthma drugs market. It examines trends and factors influencing demand for asthma drugs globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for asthma drugs across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on asthma drugs. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global asthma drugs market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for asthma drugs are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Asthma Drugs Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Asthma Drugs Market

5.1. Covid-19: Asthma Drugs Industry Impact
5.2. Asthma Drugs Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Asthma Drugs Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Asthma Drugs Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Asthma Drugs Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of asthma, along with increase in ageing population
6.1.1.2. Increase in pipeline products growth in initiatives implemented by the government and non-government associations for rise in health awareness
6.1.2. Market Restraints
6.1.2.1. Stringent government regulatory requirement for the approval of asthma drugs
6.1.3. Market Opportunities
6.1.3.1. Major companies are focusing on broadening their product portfolio

Chapter 7. Global Asthma Drugs Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Asthma Drugs Market Revenue by Market Players (2017 – 2020)
7.1.1.2. Asthma Drugs Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Process Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Asthma Drugs Market, By Medication Type

8.1. Asthma Drugs Market, by Medication Type, 2017-2030
8.1.1. Quick Relief Medications
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Long-term Control Medications
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Asthma Drugs Market, By Mode of Administration

9.1. Asthma Drugs Market, by Mode of Administration, 2017-2030
9.1.1. Tablets and Capsules
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Liquids
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Inhalers
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Injections
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Sprays and Powders
9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Asthma Drugs Market, By Source

10.1. Asthma Drugs Market, by Source, 2017-2030
10.1.1. Environmental
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Generic
10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Asthma Drugs Market, By Organization Type

11.1. Asthma Drugs Market, by Application, 2017-2030
11.1.1. Public
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Private
11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Asthma Drugs Market, By Application

12.1. Asthma Drugs Market, by Application, 2017-2030
12.1.1. Pediatric
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Adults
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Adolescent
12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Asthma Drugs Market, Regional Estimates and Trend Forecast

13.1. North America
13.1.1. Market Revenue Forecast by Medication Type (2017-2030)
13.1.2. Market Revenue Forecast by Mode of Administration (2017-2030)
13.1.3. Market Revenue Forecast by Source (2017-2030)
13.1.4. Market Revenue Forecast by Organization Type (2017-2030)
13.1.5. Market Revenue Forecast by Application (2017-2030)
13.1.6. U.S
13.1.6.1. Market Revenue Forecast (2017-2030)
13.1.7. Canada
13.1.7.1. Market Revenue Forecast (2017-2030)
13.2. Europe
13.2.1. Market Revenue Forecast by Medication Type (2017-2030)
13.2.2. Market Revenue Forecast by Mode of Administration (2017-2030)
13.2.3. Market Revenue Forecast by Source (2017-2030)
13.2.4. Market Revenue Forecast by Organization Type (2017-2030)
13.2.5. Market Revenue Forecast by Application (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue Forecast (2017-2030)
13.2.7. Germany
13.2.7.1. Market Revenue Forecast (2017-2030)
13.2.8. France
13.2.8.1. Market Revenue Forecast (2017-2030)
13.2.9. Rest of EU
13.2.9.1. Market Revenue Forecast (2017-2030)
13.3. Asia Pacific (APAC)
13.3.1. Market Revenue Forecast by Medication Type (2017-2030)
13.3.2. Market Revenue Forecast by Mode of Administration (2017-2030)
13.3.3. Market Revenue Forecast by Source (2017-2030)
13.3.4. Market Revenue Forecast by Organization Type (2017-2030)
13.3.5. Market Revenue Forecast by Application (2017-2030)
13.3.6. China
13.3.6.1. Market Revenue Forecast (2017-2030)
13.3.7. India
13.3.7.1. Market Revenue Forecast (2017-2030)
13.3.8. Japan
13.3.8.1. Market Revenue Forecast (2017-2030)
13.3.9. Rest of APAC
13.3.9.1. Market Revenue Forecast (2017-2030)
13.4. LATAM
13.4.1. Market Revenue Forecast by Medication Type (2017-2030)
13.4.2. Market Revenue Forecast by Mode of Administration (2017-2030)
13.4.3. Market Revenue Forecast by Source (2017-2030)
13.4.4. Market Revenue Forecast by Organization Type (2017-2030)
13.4.5. Market Revenue Forecast by Application (2017-2030)
13.4.6. Brazil
13.4.6.1. Market Revenue Forecast (2017-2030)
13.4.7. Rest of LATAM
13.4.7.1. Market Revenue Forecast (2017-2030)
13.5. Middle East and Africa (MEA)
13.5.1. Market Revenue Forecast by Medication Type (2017-2030)
13.5.2. Market Revenue Forecast by Mode of Administration (2017-2030)
13.5.3. Market Revenue Forecast by Source (2017-2030)
13.5.4. Market Revenue Forecast by Organization Type (2017-2030)
13.5.5. Market Revenue Forecast by Application (2017-2030)
13.5.6. GCC
13.5.6.1. Market Revenue Forecast (2017-2030)
13.5.7. North Africa
13.5.7.1. Market Revenue Forecast (2017-2030)
13.5.8. South Africa
13.5.8.1. Market Revenue Forecast (2017-2030)
13.5.9. Rest of MEA
13.5.9.1. Market Revenue Forecast (2017-2030)

Chapter 14. Company Profiles

14.1. Pfizer
14.1.1. Company Overview, Business Information, Regional Presence
14.1.2. Product Portfolio Analysis
14.1.2.1. Product Details, Specification, Product Type
14.1.3. Revenue, Price, and Gross Margin (2017-2020)
14.1.4. Recent Developments and Strategies
14.2. GlaxoSmithKline
14.2.1. Company Overview, Business Information, Regional Presence
14.2.2. Product Portfolio Analysis
14.2.2.1. Product Details, Specification, Product Type
14.2.3. Revenue, Price, and Gross Margin (2017-2020)
14.2.4. Recent Developments and Strategies
14.3. Novartis
14.3.1. Company Overview, Business Information, Regional Presence
14.3.2. Product Portfolio Analysis
14.3.2.1. Product Details, Specification, Product Type
14.3.3. Revenue, Price, and Gross Margin (2017-2020)
14.3.4. Recent Developments and Strategies
14.4. Merck
14.4.1. Company Overview, Business Information, Regional Presence
14.4.2. Product Portfolio Analysis
14.4.2.1. Product Details, Specification, Product Type
14.4.3. Revenue, Price, and Gross Margin (2017-2020)
14.4.4. Recent Developments and Strategies
14.5. Boehringer Ingelheim
14.5.1. Company Overview, Business Information, Regional Presence
14.5.2. Product Portfolio Analysis
14.5.2.1. Product Details, Specification, Product Type
14.5.3. Revenue, Price, and Gross Margin (2017-2020)
14.5.4. Recent Developments and Strategies
14.6. AstraZeneca
14.6.1. Company Overview, Business Information, Regional Presence
14.6.2. Product Portfolio Analysis
14.6.2.1. Product Details, Specification, Product Type
14.6.3. Revenue, Price, and Gross Margin (2017-2020)
14.6.4. Recent Developments and Strategies
14.7. Roche
14.7.1. Company Overview, Business Information, Regional Presence
14.7.2. Product Portfolio Analysis
14.7.2.1. Product Details, Specification, Product Type
14.7.3. Revenue, Price, and Gross Margin (2017-2020)
14.7.4. Recent Developments and Strategies
14.8. Teva Pharmaceutical
14.8.1. Company Overview, Business Information, Regional Presence
14.8.2. Product Portfolio Analysis
14.8.2.1. Product Details, Specification, Product Type
14.8.3. Revenue, Price, and Gross Margin (2017-2020)
14.8.4. Recent Developments and Strategies
14.9. Vectura Group
14.9.1. Company Overview, Business Information, Regional Presence
14.9.2. Product Portfolio Analysis
14.9.2.1. Product Details, Specification, Product Type
14.9.3. Revenue, Price, and Gross Margin (2017-2020)
14.9.4. Recent Developments and Strategies

Chapter 15. Appendix

15.1. About Us
15.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1225

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →